Category: Vaccines

Pfizer’s Covid Cash Powers a ‘Marketing Machine’ on the Hunt for New Supernovas

While sales of its covid vaccines are falling, Pfizer plans to triple the price of the shots and use its bonanza from government contracts to buy and develop new blockbusters.

KHN’s ‘What the Health?’: Voters Will Get Their Say on Multiple Health Issues

Abortion isn’t the only health issue voters will be asked to decide in state ballot questions next month. Proposals about medical debt, Medicaid expansion, and whether health care should be a right are on ballots in various states. Meanwhile, the latest lawsuit challenging the Affordable Care Act has expanded to cover all preventive care. Alice Miranda Ollstein of Politico, Jessie Hellmann of CQ Roll Call, and Victoria Knight of Axios join KHN’s Julie Rovner to discuss these topics and more.

As Links to MS Deepen, Researchers Accelerate Efforts to Develop an Epstein-Barr Vaccine

Recent leaps in medical research have lent urgency to the quest to develop a vaccine against Epstein-Barr, a ubiquitous virus that has been linked to a range of illnesses, from mononucleosis to multiple sclerosis and several cancers.

As Links to MS Deepen, Researchers Accelerate Efforts to Develop an Epstein-Barr Vaccine

Recent leaps in medical research have lent urgency to the quest to develop a vaccine against Epstein-Barr, a ubiquitous virus that has been linked to a range of illnesses, from mononucleosis to multiple sclerosis and several cancers.

Commercialization of COVID-19 Vaccines, Treatments, and Tests: Implications for Access and Coverage

With the depletion of the federal-purchased supply of COVID-19 vaccines, treatments and tests following the end of the public health emergency, this resource provides an overview of the implications of these changes for access to people covered by Medi…

Will Covid Spike Again This Fall? 6 Tips to Help You Stay Safe

Recent research suggests that the covid virus is mutating to better dodge people’s immune defenses. It could soon evade monoclonal antibodies used to treat covid. KHN examines what public health officials believe is on the horizon and how best to fight the disease.

Watch: What Experts Advise for Seniors Living Under the Long Shadow of Covid

For older people, the pandemic is as taxing and worrisome as ever. Experts in geriatric care, mental health, social services, and infectious disease joined a KHN-Hartford Foundation panel to talk about a third covid winter and its outsize toll on seniors.

Is Covid ‘Under Control’ in the US? Experts Say Yes

PolitiFact has been tracking this campaign promise since 2020. Experts are now saying it’s fair to describe the covid pandemic as “under control.”

Covid Still Kills, but the Demographics of Its Victims Are Shifting

Californians were far less likely to die from covid in the first seven months of 2022 than during the first two years of the pandemic. Still, the virus remained among the state’s leading causes of death in July, outpacing diabetes, accidental death, and a host of debilitating diseases. We break down who’s at risk.

With Polio’s Return, Here’s What Back-to-Schoolers Need to Know

Because polio has been vanishingly rare in the United States for nearly a half-century, doctors may not consider it when diagnosing patients with typical symptoms. Here are the signs and the science behind an infectious disease that is largely a mystery to modern society.